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ABSTRACT
Heavy metal compounds have toxic and medicinal
potential through capacity to form strong specific
bonds with macromolecules, and the interaction of
platinum drugs at the major groove nitrogen atom of
guanine bases primarily underlies their therapeutic
activity. By crystallographic analysis of transition
metal–and in particular platinum compound–DNA
site selectivity in the nucleosome core, we establish
that steric accessibility, which is controlled by spe-
cific structural parameters of the double helix, modu-
lates initial guanine–metal bond formation. Moreover,
DNA conformational features can be linked to both
similarities and distinctions in platinum drug adduct
formation between the naked and nucleosomal
DNA states. Notably, structures that facilitate initial
platinum–guanine bond formation can oppose
cross-link generation, rationalizing the occurrence
of long-lived therapeutically ineffective monofunc-
tional adducts. These findings illuminate DNA
structure-dependent reactivity and provide a novel
framework for understanding metal–double helix
interactions, which should facilitate the development
of improved chromatin-targeting medicinal agents.
INTRODUCTION
The pathologic and medicinal potential of heavy metal
compounds relates closely to their ability to form strong
bonding interactions with various biomolecules (1). Inside
the cell, such bonding potential translates to the ability to
elicit pronounced and long-lasting conformational
changes in proteins and nucleic acids. The pharmaco-
logical effect of platinum-based chemotherapeutic agents
(Supplementary Figure S1) is mediated through formation
of DNA lesions, which interfere with genomic activities
and ultimately trigger apoptosis (2,3). When these agents
enter the low chloride anion environment within the cell,
the chloride or carboxylate leaving groups can undergo
aquation, generating reactive aqua-species. Initial attack
on DNA coincides with formation of a single Pt–purine
bond, corresponding to the monofunctional adduct (MFA),
followed by potential chelation to yield a bifunctional ad-
duct (cross-link). Drug reaction occurs at the N7 nitrogen
atoms of purine bases, generating predominantly 1,2
intrastrand cross-links at GG and less frequently at AG
dinucleotides, in addition to a minor fraction of GNG 1,3
intrastrand and other DNA adducts. The primary mech-
anism of action appears to relate to local dinucleotide kink
distortions and double helix deformations that cause tran-
scriptional arrest through stalling RNA polymerase (3).
In spite of their widespread application for decades
in the treatment of speciﬁc cancers and the execution
of many thousands of clinical and chemical studies, the
principles dictating platinum drug site selectivity and
cross-link formation are not well understood. In fact,
the markedly non-uniform distribution of drug adducts
observed for cellular DNA and for DNA in in vitro
studies (4,5) indicate that site preference is governed by
attributes that go beyond the guanine nucleotide distribu-
tion. Additionally, there is a lack of consensus on some of
the basic mechanistic features (6,7), which likely arises
from the fact that investigations have been based on one
or several short DNA fragments of distinct sequence,
yielding little overlap between related studies.
The fact that current platinum drugs elicit severe toxicity
and resistance effects has prompted the search for safer
and more effective agents (8). However, a full understand-
ing of the mechanism of action—the weak points of cancer
cells that are exploited—and the directed design of
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improved agents will depend on a detailed knowledge of
drug adduct formation (9). Here, we have conducted a
detailed biochemical, structural and analytical study with
a variety of nucleosomal and naked DNA substrates to
delineate the attributes underlying transition metal site
preference and platinum compound adduct formation.
Our ﬁndings shed light on the fundamental principles that
govern platinum drug site selection and the generation of
therapeutically active cross-links in the genome.
MATERIALS AND METHODS
Platinum compounds
Cisplatin (cisPt), carboplatin (carPt) and oxaliplatin (oxPt)
were purchased from Sigma–Aldrich (Supplementary
Figure S1). [(NH3)3PtCl]Cl (tamPt) and [(1,2-R,R-
diaminocyclohexane)PtCl2] (clPt) were prepared accord-
ing to established protocols (10,11). The purity of the com-
mercially available compounds was 98–99% and that of
the synthesized compounds was found to be >98% ac-
cording to elemental analysis.
Nucleosome core particle generation and crystal
preparation
Nucleosome core particle (NCP) constructs, NCP145,
NCP146, NCP146b, NCP147 andNCP-TA, were prepared
from recombinant Xenopus laevis histones and 145, 146
and 147 bp DNA fragments using established protocols
(1215). NCP crystals were grown as described previ-
ously and stabilized in a chloride-free substitute har-
vest buffer of 10mM MnSO4, 50mM K-cacodylate
(pH 6.0), 24% (v/v) 2-methyl-2,4-pentanediol and 2%
(w/v) trehalose (16).
Structural data reported here were obtained from NCP
crystals derivatized by including Pt agent in the substitute
harvest buffer at concentrations of 2mM tamPt, 0.6mM
oxPt, 0.6mM cisPt (1- to 2-day treatments) or 0.3mM
cisPt (4-day treatments). Crystals were subsequently
allowed to incubate at room temperature for up to
4 days prior to data collection (17).
Structure solution and analysis
Single crystal X-ray diffraction data were recorded as
described previously (13) at the Swiss Light Source (Paul
Scherrer Institute, Villigen, Switzerland) using the
PILATUS detector on beam line X06SA and a Mar225
CCD detector on beam line X06DA. The X-ray wave-
length was tuned to the absorption edge of platinum
(1.07 A˚) for data collection. Data were processed with
MOSFLM (18) and SCALA from the CCP4 suite (19).
Structural reﬁnement and model building were carried
out with routines from the CCP4 suite. Structures for
NCP145 and NCP146b in MnSO4 buffer, at 2.5 A˚ reso-
lution and 2.55 A˚ resolution respectively, were solved by
initial rigid body reﬁnement of the earlier 2.65 A˚ NCP145
model (13) and the original 2.6 A˚ NCP146b model (12).
Pt-derivatized NCP145 and NCP146b structures were
solved by initial rigid body reﬁnement of the (native)
MnSO4 models. Pt occupancy and B-factor values were
reﬁned against the anomalous difference data using
Mlphare (19). The initial occupancy values, on an arbi-
trary scale, were normalized with respect to the Pt atom
having highest occupancy in the structure, which was
assigned a value of 1.00.
Solvent accessible surface area (ASA) values for purine
N7 atoms were obtained with the ArealMol routine of the
CCP4 suite (19), using the default water molecule probe
radius of 1.4 A˚. In order to provide insight into the rela-
tionship between the initial DNA conformation, prior to
soft metal coordination and the binding site preference for
these metal species, we carried out the analyses such that
Pt2+, Co2+ or Ni2+ crystallographic site occupancy was
compared with the DNA structure of the respective native
NCP crystals prepared in Mn2+ buffers. For the Pt com-
pounds, the native MnSO4-models of NCP146b and
NCP145 were utilized, which contain, respectively, a
total of 60 and 58 guanine sites having an average
guanine-N7-atom-ASA (ASAN7) of 10.7±3.5 A˚
2 and
10.3±4.1 A˚2. For the 13- and 55-h tamPt and the 14-,
25- and 57-h oxPt treatments of NCP146b, 57, 55, 58, 57
and 58 guanine sites, respectively, are considered in the
analysis. For the 13- and 55-h tamPt treatments of
NCP145, 58 and 54 guanine sites, respectively, are con-
sidered in the analysis. The one to ﬁve guanine sites that
were omitted from analysis in any case correspond to
dynamic locations mostly near the DNA termini where
Pt is observed to bind but displays a coordination distance
3 A˚. In these instances, MFA formation is either
preceded or accompanied by a substantial conformational
change in the DNA, which cannot be differentiated.
In the analysis of DNA structure relative to Co2+/Ni2+
site occupancy, the comparison model was the 1.94 A˚ reso-
lution NCP147 MnCl2 structure (12), which contains 60
guanine sites having an average ASAN7 of 9.5±4.0 A˚
2.
The analysis considered 105 bp of the 147 bp DNA, which
excludes a central 42 bp section that undergoes substantial
conformational changes from a Co2+/Ni2+-stabilized
translation in the histone–DNA register arising from sub-
stitution of the intermediate-soft metals in place of Mn2+
in the crystals (20). The ﬁnal guanine nucleotide set
used for the analysis entailed 29 sites, whereby
cross-linked GG dinucleotide sites (bifunctional coordin-
ation to both the 50 G-N7 and 30 G-O6 atoms), which
involve a more complex reaction than MFA formation,
were excluded from the analysis. The Mn2+ analysis was
based on the metal occupancy values from the 2.75 A˚ reso-
lution NCP147 MnSO4 data (21), collected at the manga-
nese absorption edge, and the ASAN7 values from the
1.94 A˚ resolution NCP147 MnCl2 structure (12). The
analysis included either the same set of 29 guanine sites
for direct comparison with the Co2+/Ni2+ systems or the
full complement of 56 sites (4 guanine nucleotides at GG
sites involved in bifunctional Mn2+ coordination were
omitted from the analysis).
DNA conformational analysis was conducted using
3DNA (22,23). Graphic ﬁgures were prepared with
PyMOL (DeLano Scientiﬁc LLC, San Carlos, CA,
USA). Principal component and statistical analyses were
carried out with the XLSTAT routine of Microsoft Excel
(Microsoft Corporation).
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DNA footprinting and interstrand cross-linking analysis
Exonuclease III footprinting experiments for obtaining Pt
adduct formation proﬁles, based on digest (30–50 direction)
termination at DNA lesion sites, were conducted as
described previously (16). 20 micromolar naked DNA
or NCP in a buffer of 20mM K-cacodylate (pH 6.0)
were incubated with 5-, 5-, 5-, 20- or 200-fold molar
excesses of cisPt, tamPt, clPt, oxPt or carPt, respectively,
at room temperature for 48 h. For the low stoichiometry
treatment shown in Supplementary Figure S12, only a
10-fold molar excess of oxPt was utilized. Samples were
treated by heating at 55C with the addition of 4M NaCl
to a ﬁnal concentration of 2M, followed by phenol–
chloroform extraction and ethanol precipitation of the
DNA, which was then 50end-labelled with polynucleotide
kinase. 675ng DNA samples were subjected to digestion
with 250U of exonuclease III for 1 h, which is a 10-fold-
excess over that minimally required for full digestion of
the unplatinated DNA. The one exception corresponds to
the ‘one-third’ digest shown in the left panel of
Supplementary Figure S11, in which the tamPt samples
were digested with one-half as much enzyme for only
40min. After ethanol precipitation, digested DNA
samples were subsequently deplatinated at 58C by treat-
ment with 1M thiourea for 16 h, followed again by ethanol
precipitation of the DNA. Modiﬁed Maxam–Gilbert
purine sequencing standards were prepared initially as
described (24), followed by 30 dephosphorylation by treat-
ment with 1 U of polynucleotide kinase per 20 ng DNA
for 16 h. DNA fragments were resolved by denaturing
PAGE (10% polyacrylamide, 8M urea, 88mM Tris–
borate, 2mM EDTA, pH 8.3), in which loaded
quantities of Pt agent-treated DNA samples corresponded
to approximately equal total radioactive counts visible on
the gel.
For the interstrand cross-linking analysis, 20 mM naked
DNA or NCP in a buffer of 20mM K-cacodylate (pH 6.0)
were incubated with 10-, 10-, 20- or 200-fold molar
excesses of cisPt, tamPt, oxPt or carPt, respectively, at
room temperature for 48 h (NCP146b and NCP145
samples). For the NCP-TA samples, 5-, 10-, 10- or
200-fold molar excesses of cisPt, clPt, oxPt or carPt, re-
spectively, were utilized. Samples were treated by heating
at 55C with the addition of 4M NaCl to a ﬁnal concen-
tration of 2M, followed by phenol–chloroform extraction
and ethanol precipitation of the DNA, which was then
50end-labelled with polynucleotide kinase. DNA frag-
ments were subsequently resolved by denaturing PAGE
(10% polyacrylamide, 8M urea, 88mM Tris–borate,
2mM EDTA, pH 8.3), with equivalent DNA quantities
loaded for all samples.
Quantiﬁcation of platinum adducts
The Pt agent:DNA molar stoichiometries of treatment
used for the footprinting studies were chosen to achieve
an approximately equal number of adducts per DNA
molecule across the ﬁve different Pt compounds and be-
tween the naked and nucleosomal DNA samples. Samples
were prepared by incubating 20 mM naked DNA or NCP
in a buffer of 20mM K-cacodylate (pH 6.0) with 5-, 5-, 5-,
20- or 200-fold molar excesses of cisPt, tamPt, clPt, oxPt
or carPt, respectively, at room temperature for 48 h.
Naked or nucleosomal DNA samples were subsequently
prepared by heating either naked DNA or aliquots of
NCP at 55C with the addition of 4M NaCl to a ﬁnal
concentration of 2M, followed by phenol–chloroform ex-
traction and ethanol precipitation of the DNA. DNA con-
centrations prior to Pt quantiﬁcation were determined by
spectrophotometric absorbance measurements at 260 nm.
A Hitachi Z-2000 polarized Zeeman atomic absorption
spectrophotometer was used to measure Pt content in
the samples as described previously (25).
Measurements were conducted in duplicate over two
independent trials and averaged between the ﬁve Pt com-
pounds, yielding an average number of adducts per DNA
molecule of 3.9±0.7 and 3.5±0.7 for the naked DNA
and nucleosomal DNA states, respectively, for NCP146b
samples. The corresponding naked and nucleosomal DNA
values for NCP145 samples were 4.8±1.3 and 4.1±1.2,
respectively. Adduct levels for the intact NCP were sys-
tematically higher, at 4.9±1.2 and 5.1±1.1, for
NCP146b and NCP145, respectively. This is an apparent
consequence of Pt agent reaction with histone methionine
sulphur groups (16), causing more extensive overall
adduct accumulation compared to DNA substrate alone.
RESULTS
Platinum adduct formation is modulated by
solvent accessibility
We studied here the three most widely used platinum
drugs, cisPt, carPt and oxPt, in addition to two other
related compounds—tamPt and clPt (Supplementary
Figure S1). In an earlier study on Pt drug-nucleosome
site selectivity, we were able to observe adducts by X-ray
crystallographic analysis of NCP crystals that had been
treated with cisPt or oxPt, but this caused substantial re-
duction in diffraction quality from disordering of the
crystals (16). In that initial study, we had utilized an
NCP (NCP147) containing a 147 bp human a-satellite
DNA fragment, which yielded roughly 3.5 A˚ resolution
data sets. We subsequently experimented with different
substrates and observed that crystals are profoundly
more tolerant to Pt compound treatment when the NCP
is composed of a 146 or 145 bp DNA. Disordering of these
NCP146b and NCP145 crystals from platination is appar-
ently much less severe than for NCP147 as a result of a
‘buffering’ effect from DNA stretching (see below).
It was possible to obtain up to 2.5 A˚ resolution data sets
for NCP146b or NCP145 crystals heavily derivatized by
tamPt, oxPt or cisPt (Supplementary Tables S1 and S2;
the low reactivity of carPt and low solubility of clPt did
not allow extensive derivatization of crystals on a reason-
able time scale). By exploiting a special form of heavy
atom X-ray scattering through tuning the X-ray wave-
length to the absorption edge of platinum, we obtained
exceptional proﬁles of Pt2+ ion location and site occu-
pancy from the anomalous difference electron density
maps (Figure 1 and Supplementary Figures S2S4).
With the exception of the nearly fully solvent accessible
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N7 atoms of the 50 terminal adenine bases of NCP145 and
NCP146b (average solvent accessible surface area=
23.2±2.4 A˚2)—the primary sites of adduct formation
for oxPt—all other apparent sites of MFA formation on
the DNA coincide with G-N7 groups. Aside from this
DNA terminus artifact, the minor fraction of Pt adducts
that initially appear to have formed at non-guanine sites
or with unreasonable coordination geometry apparently
relate to conformational changes in the double helix,
which can be linked back to alterations in the DNA
stretching conﬁguration (Figure 2).
DNA stretching is an intrinsic property of the nucleo-
some that is apparently conﬁned to two unique locations
where the histone binding conﬁguration induces strain in
the double helix (27); (Supplementary Figure S5). As such,
the DNA is either compressed and undertwisted in the
unstretched state or elongated and overtwisted in the
stretched state. The stretched conformation is frequently
accompanied by extreme kink distortions and is achieved
through elevated dinucleotide twist and rise, which alters
the histone-DNA register by increasing the ‘effective’
double helix length by 1 bp (13,28).
While the native NCP145 structure displays two inci-
dences of stretching around SHL (SuperHelix Location,
double helical turns from the nucleosome center)±2 and
that of native NCP146b displays one incidence of
stretching around SHL 5, NCP in solution and in the
crystalline state can contain a mixture of stretching con-
ﬁgurations (12,13,29–31); (Supplementary Figure S5). For
NCP145 and NCP146b derivatization with cisPt, oxPt and
tamPt, one observes adducts coinciding with at least two
distinct stretching states for each NCP construct
(Supplementary Figures S3 and S4). For tamPt and oxPt
treatments of NCP146b, this appears to relate solely to
two conﬁgurations; namely the predominant initial
stretching at SHL 5 (only) and a secondary minor inci-
dence where the stretch has relocalized to the opposing
particle half (SHL 5). Thus, adduct formation is
Figure 1. Monofunctional Pt adduct formation in the nucleosome core. (A and B) Anomalous difference electron density maps (3.5s-cyan,
4.5s-magenta, A; 3.5s, B) from 13- and 55-h tamPt treatments of NCP145 (A) and NCP146b (B) are superimposed on the respective reﬁned
55-h models. Values in A˚ represent bond distances between Pt (silver spheres) and G-N7 [based on peak positions in the anomalous map; ideal bond
length is 2.0 A˚ (26)] and numbers in parentheses correspond to ASAN7 (A˚2). A green dot designates the base pair at the nucleosome centre,
through which the pseudo 2-fold axis of symmetry runs vertically (A). Alternating dinucleotide shift (displacement of base pairs into the major and
minor grooves; arrows) causes pronounced ﬂuctuation in consecutive ASAN7 values (B). (C) The chemical structure of the monofunctional agent,
tamPt.
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observed as a superimposition of these two NCP146b
stretching conformations and the corresponding site se-
lectivity can be derived by adduct assignment with
respect to one or the other conﬁguration (Figure 2).
As we had observed before for NCP147 (16), cisPt treat-
ment of NCP145 and NCP146b gives rise to substantial
disordering of the DNA, precluding comprehensive as-
signment of adduct formation proﬁles. Therefore, we
utilized the data from the most extensive treatments of
NCP146b with tamPt and oxPt and NCP145 with tamPt
to analyse the relationship between DNA structure and
adduct formation. Although there are several sites where
some signiﬁcant conformational change in the DNA must
occur before or during adduct formation, the vast
majority of sites coincide with the Pt2+ ion situated with
roughly ideal bonding geometry with respect to the G-N7
atom (Figures 1 and 2, Supplementary Figures S3 and S4).
In fact, these three heavily platinated structures are nearly
identical to the corresponding native models (rmsd in
DNA atomic positions of 0.3 A˚ in each case).
We had originally identiﬁed several DNA conform-
ational features, which can inﬂuence the favourability or
mode of divalent transition metal cation coordination at
speciﬁc sites in the NCP (20,21,32). Here, we conducted a
novel analysis uncovering a general principle that governs
site selectivity—the ASAN7 (NCP146b average=
10.7±3.5 A˚2; NCP145 average=10.3±4.1 A˚2) dictates
the proclivity for MFA formation at these major groove
sites. The correlations between NCP146b-Pt site occu-
pancy and ASAN7 (Pearson’s r=0.66, tamPt; r=0.54,
oxPt) (Supplementary Figures S6 and S7) are substantial,
especially considering the general disordering effects of Pt
adduct formation together with the large number of sites
considered in the analyses (up to 58 guanine sites).
Furthermore, the clustering of occupied and unoccupied
tamPt and oxPt sites at high (13.1±1.9 A˚2, tamPt;
12.8±2.7 A˚2, oxPt) and low (8.3±3.4 A˚2, tamPt;
8.9±3.3 A˚2, oxPt) ASAN7 values is pronounced and the
most accessible guanine sites tend to be the ﬁrst to accu-
mulate adducts. In addition, although localized disorder-
ing from oxPt treatment of NCP145 crystals does not
allow comprehensive site assignment (Supplementary
Figure S4), the same inﬂuence of ASAN7 can be seen for
NCP145-tamPt site selectivity (r=0.67; 12.9±2.8 A˚2,
occupied; 7.5±3.2 A˚2, vacant) (Supplementary Figure
S8). It is important to note that NCP145 is a distinct sub-
strate, since it shares only 42% DNA sequence identity
with NCP146b. As observed for MFA formation by the
Pt compounds, we ﬁnd that elevated ASAN7 also strongly
promotes monofunctional binding of Mn2+, Ni2+ and Co2+
to NCP147 (Supplementary Figures S9 and S10,
Supplementary Table S3).
Speciﬁc DNA conformational features dictate steric access
The stacking of bases in double helical DNA limits solvent
accessibility within the major and minor grooves. Since
ASAN7 modulates metal–DNA bond formation and
varies dramatically over different locations, we wanted
to determine if there are conformational features that pri-
marily govern this parameter. We started by considering
the change in ASAN7 with respect to changes in the six
base pair step degrees of freedom for an idealized B-form
DNA molecule (Supplementary Table S4). Importantly,
the twist of the double helix renders the inﬂuence on
ASAN7 of the 5
0 base and the 30 base ﬂanking a particular
base site distinct. Accordingly, this fundamental analysis
shows that increases in the values of 50 shift, tilt, slide and
rise and 30 tilt, twist and rise yield an increase in ASAN7,
whereas, conversely, decreases in the values of 50 roll and
twist and 30 shift, roll and slide yield increases in ASAN7
(Figure 3).
For assessing the empirical relationship between double
helix conformation and ASAN7, we utilized the highest
Figure 2. Pt adduct formation in NCP crystals reveals a minor popu-
lation with an alternate histone-DNA register. (A and B) Anomalous
difference electron density maps (3.5s, A; 4s, B) from 13- and 55-h
tamPt treatments of NCP146b are superimposed on the reﬁned 55-h
model (blue). A minor fraction of NCPs in the crystal have DNA
stretching around SHL 5 as opposed to around SHL 5 (yellow; see
Supplementary Figure S5), whereby the histone-DNA register relative
to the major conformation (blue; stretching around SHL 5 and not
around SHL 5) is translated by 1 bp (arrows). The minor conformation
structure (yellow) corresponds to the opposing particle half of the
reﬁned model, which was superimposed via the histone fold regions.
Values in A˚ represent bond distances between Pt (spheres) and G-N7
(A) or purine-N7 (B) and numbers in parentheses correspond to ASAN7
(A˚2; B). Adduct-to-base correspondence is apparent from coordination
geometry, base chemistry and anomalous map proﬁle. Adducts
associated with the minor stretching conﬁguration are highlighted
with a red asterisk.
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resolution native NCP model (NCP147; 12), as well as those
of NCP146b and NCP145 (Supplementary Table S5). The
main determinant of the ASAN7 is shift, which makes a far
greater contribution than any of the other parameters ap-
parently because it corresponds to direct displacement
into the major groove solvent space. The relative contri-
butions of 50 versus 30 shift differ somewhat, but we deﬁne
a new parameter, protrusion, that equates to the sum dis-
placement into the major groove with respect to both
50 and 30 base neighbours (Figure 3), and this parameter
gives the highest single correlation with ASAN7.
From restraints imposed by the DNA backbone and
base stacking interactions (in real DNA) alterations in
roll are coupled to inverse changes of twist and slide and
alterations in shift are coupled to changes in tilt
(Supplementary Table S6). Therefore, although shift is
clearly the driver of ASAN7 modulation, the contribution
of 50 shift is greater than that of 30 shift (Supplementary
Table S5), apparently because 50 shift and tilt are in phase
with each other and make a uniﬁed contribution
to ASAN7, while the 3
0 parameters are out of phase
(Figure 3). Likewise, neither the 50 nor 30 individual con-
tributions of roll, twist and slide towards ASAN7 have the
appropriate phase relationships to provide a uniﬁed input,
which presumably underlies their much weaker overall
inﬂuence relative to shift.
Analysis of the platinated NCP146b and NCP145
models shows the predominance of shift in inﬂuencing
tamPt and oxPt adduct formation (Supplementary
Table S7). Moreover, the contribution of 50 shift is sub-
stantially stronger than that of 30 shift, which may relate
to special steric demands imposed by the 50 base. This is
consistent with the fact that (for NCP146b) 50 roll in the
negative direction is also seen to signiﬁcantly facilitate
adduct formation—by increased steric clearance over the
major groove edge accompanying bending into the minor
groove (Figure 3). Such dominance by the 50 side is likely a
consequence of the fact that, due to the right-handed twist
Figure 3. Inﬂuence of DNA conformational elements on solvent accessibility within the major groove. The directional change (Inc, increase; Dec,
decrease) for each of the six dinucleotide step parameters that yields an increased ASAN7 for the central guanine base is shown for idealized GGG
trinucleotides (entailing a 50 and a 30 GG dinucleotide step). The ‘canonical’ reference point has values of 35 for twist, 3.3 A˚ for rise and 0 for the
remaining four step parameters. The ‘+’ and ‘’ symbols indicate the general conformational coupling that occurs in real DNA; shift and tilt are
positively correlated, whereas roll is anti-correlated with twist and slide. With consideration of this coupling, parameters on either the 50 or 30 side
that cannot work in a cooperative fashion with either shift or roll to elevate ASAN7 are indicated with arrows in green.
Nucleic Acids Research, 2011, Vol. 39, No. 18 8205
of the double helix, the 50 ﬂanking base is effectively
rotated into the major groove relative to a G-N7 site, po-
tentially blocking access from the 50 direction—a circum-
stance opposite to that of the 30 base, which is effectively
recessed.
DNA structure modulates platinum drug cross-link
formation
We had earlier discovered through footprinting analysis of
naked and nucleosomal DNA substrates that histone
octamer association can modulate cisPt and oxPt adduct
formation proﬁles (16). This analysis was expanded here
to include four NCP constructs and ﬁve Pt compounds
(Figure 4, Supplementary Figures S11 and S12). We had
originally assumed that exonuclease stop sites before
isolated guanine nucleotides corresponded to MFAs.
However, we ﬁnd that our standard footprinting analysis
of naked and nucleosomal templates treated with tamPt—
which is capable of forming essentially only MFAs
(Supplementary Figure S13)—yields almost no stop sites,
indicating that MFAs are digested through much more
Figure 4. Exonuclease digest analysis reveals Pt cross-link formation proﬁles. DNA samples, comprising four different NCP constructs, correspond
to purine sequencing standard (m) or naked DNA (‘D’) and NCP (N) that were treated with oxPt (A), clPt (B), cisPt (C) or carPt (D). Minor groove
inward-facing bases (highlighted in orange), regions of DNA stretching (magenta arrows) and the central nucleotide (green dot) are based on the
native crystal structure assignments (Supplementary Figure S5; the palindromic DNA sequences read from 50, bottom of gel, to 30, top of gel).
Prominent intrastrand cross-links at GG, AG, GA or GNG sites are indicated by red asterisks placed at the apparent purine nucleotides of the
bifunctional adducts. Interstrand cross-links at GC sites within SHL ±0.5, ±1.5, ±2.5 and ±5.5 coincide with nuclease arrest upstream (30) of
guanine in either DNA strand (blue lines; multiple stop pairs are apparent in some cases). For clarity, cross-link features are illustrated only for the
nucleosomal DNA (N) samples. See Supplementary Figure S12 for an illustration of cross-link assignment from stop site proﬁles.
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(continued)
readily than cross-links (Supplementary Figure S11).
Accordingly, this shows that the footprints of the four
bifunctional agents correspond effectively to cross-link
formation proﬁles.
The related 145, 146 and 147 DNA constructs each
contain four unique GC dinucleotides while the 146b
construct contains three such elements (Supplementary
Figure S5), and we observed a substantial degree of inter-
strand cross-linking in both the naked and nucleosomal
states (Supplementary Figure S13). With the knowledge
that the Pt adduct footprints reveal cross-linking proﬁles,
it is now apparent that many of the stop sites for the bi-
functional agents correspond to GC interstrand cross-
links (Figure 4). These stop sites arise as doublets,
whereby nuclease digestion arrests upstream of guanine
in either DNA strand. The overall intensity of the GC
stops appear disproportionate considering that only a
minor fraction of adducts correspond to interstrand
cross-links. However, by extrapolation from the relative
digestability of MFAs, cross-links that are more distorting
or cumbersome would be expected to be especially resist-
ant to nuclease digestion.
Some of the GC cross-links have enhanced prominence
in the nucleosomal relative to the naked DNA samples, in
particular at central locations (e.g. SHL ±0.5; Figure 4),
and site-speciﬁc promotion of interstrand cross-linking by
histone octamer association has been observed previously
(33). Here, all of the GC sites are at locations where the
minor groove faces inward and the centrally situated of
these (SHL ±0.5, ±1.5 and ±2.5) are regions where
minor groove bending has been found associated with
alternating shift (34). This conformational pattern yields
Figure 4. Continued
Nucleic Acids Research, 2011, Vol. 39, No. 18 8207
alternating high and low ASAN7, and indeed the former
are found to be prominent sites of MFA formation in
the crystal structures (Figure 1B and Supplementary
Figure S14). In at least one instance, with a long-duration
cisPt crystal treatment, we observe apparent interstrand
cross-link formation at the SHL 0.5 and 1.5 GC sites
of NCP145 (Supplementary Figure S15). Interestingly, the
adduct position suggests the possibility of only a nominal
conformational change associated with the cross-link, in
stark contrast to the naked DNA crystal structure of the
same cross-link type (35). Given their positions in
the NCP constructs, the positive slide associated with
the GC steps bent into the minor groove could facilitate
interstrand cross-linking by bringing the N7 atoms into
closer proximity.
The origin of DNA structure-based modulation of
interstrand GC cross-linking apparently relates to a com-
bination of ASAN7-based regulation of MFA formation
and the inﬂuence of conformational features on the che-
lation step. In this regard, the main distinctions in the
adduct formation proﬁles between the naked and nucleo-
somal states occur at locations where the two DNA forms
have the greatest potential for differences: regions near
the nucleosome centre where the histone-DNA contacts
are strongest, one-half SHLs where DNA must bend
(against its general tendency) into the minor groove and
at locations of DNA stretching (1214,28,34) (Figure 4).
Kinetics of platinum drug cross-link formation
Beyond the interstrand cross-links, the other main sites of
cross-linking apparent in the footprinting analysis are also
consistent with extensive adduct formation observed in the
crystal structures (Figure 4, Supplementary Figures S3
and S4). In fact, we had previously shown that the foot-
print of NCP in solution compared to that in the crystal-
line state is very similar (16). For the especially clear oxPt
crystal data, the most prominent cross-link formation
occurs at the respective AGGG and AGGC elements
within SHL 1.5 of NCP146b and NCP145 (Figure 5).
This is in agreement with the cross-linking hotspot seen
for oxPt and clPt in the footprinting analysis, but the
cross-linking activity of cisPt and carPt towards this
location is reduced as judged by the footprints (Figure
4). However, we do observe pronounced tamPt and cisPt
MFA formation at SHL ±1.5 in crystals, even at early
time points, which suggests that reduced cross-link forma-
tion may come about, at least in part, by inhibition of the
chelation step (Supplementary Figure S14).
Figure 5. Time lapse X-ray crystallography shows the evolution of Pt adducts. (A and B) Anomalous difference electron density maps (4s, A; 3s, B)
from 14-, 25- and 57-h oxPt treatments of NCP146b and NCP145 are superimposed on the respective reﬁned 25-h models. MFA formation occurs
early at accessible G-N7 sites of SHL ±1.5 and apparent AG and GG cross-linking ensues later at SHL 1.5 (right). Differences in DNA structure
and ﬂexibility, as a consequence of distinct histone-DNA register (A) or stretching mode (B; note the massive kink into the minor groove at the SHL
1.5 GG of NCP145) between the two particle halves in the crystal, apparently account for the observed distinctions in chelation rate between SHL
1.5 and 1.5. Values in parentheses correspond to ASAN7 (A˚2).
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Differences in oxPt cross-link formation between SHL
1.5 and 1.5 in the crystals suggest that distinctions in
DNA structure and ﬂexibility modulate the intrastrand,
as well as the interstrand, chelation rate (Figure 5). In
fact, another location at the edge of SHL ±5 shows
clear MFA formation at early time points, which can
form chelates over the GG dinucleotide at later time
points (Figure 6). Interestingly, extensive cross-link for-
mation at this GG site is observed for the nucleosomal,
but not the naked, footprint (Figure 4 and in particular
with mild oxPt treatment, Supplementary Figure S12).
This indicates nucleosome-based enhancement of
cross-linking and importantly, ensuing cross-linking is
observed crystallographically in only one of the particle
halves, wherein the absence of DNA stretching gives a
highly distinct initial conformation relative to the other
symmetry-related site for which only pronounced MFA
formation is seen (Figure 6). Comparison of the structural
parameters of these two sites with those of the oligo-
nucleotide crystal structure of an oxPt-GG cross-link
(36) indicates that the pre-reaction conformation of the
SHL 5 site that shows cross-link formation is much
more similar to the oligonucleotide structure compared
to that of SHL 5. Although the 50 G-N7 is substantially
more solvent accessible than the 30 G-N7, which explains
preferential attack at the 50 site, conformational compati-
bility appears to account for a large difference in chelation
rate. In this sense, given two sites of identical sequence, the
site with a pre-cross-linking conformation closer to that of
the cross-linked state should have a lower DNA distortion
energy barrier associated with chelation.
DISCUSSION
Mn2+, Ni2+ and Co2+ differ in coordination geometry
compared to Pt2+ (octahedral versus square planar), but
ligand substitution reactions for square planar com-
pounds, such as MFA formation by Pt drugs, are initi-
ated with weak axial coordination to the metal (37)
(Figure 7A). Thus, the initial G-N7 associative species of
Pt compounds to some extent resembles the coordination
geometry for the other transition metals. In this respect,
the different divalent metal species seemingly share a
common mode of double helix bonding, which is regulated
by solvent accessibility. For Pt compounds, sites that are
sterically inaccessible disfavour MFA formation by pre-
venting initial association and also possibly elevating the
energetic barrier for the trigonal bipyramidal ligand
exchange intermediate. Analogously, for the octahedral
metals, steric clearance from the surrounding DNA
bases is necessary for favourable water ligand interactions.
Although steric access appears to be the dominant feature
controlling guanine site selectivity for all the transition
metal species we have studied here, there are clearly add-
itional factors that inﬂuence binding (Supplementary
Figures S6–S10). In particular, details of the DNA
sequence and conformational context would affect associ-
ation by dictating electrostatic interactions and hydrogen
bonding capacity with respect to compound-speciﬁc metal
centres and ligands (Figure 7A).
Figure 6. Time lapse X-ray crystallography reveals that DNA structure
modulates Pt adduct chelation rate. (A and B) Anomalous difference
electron density maps (3.5s) from 14-, 25- and 57-h oxPt treatments
of NCP146b are superimposed on the reﬁned 25-h model. MFA
formation at the 50 G occurs early at both SHL ±5, but apparent
GG cross-linking ensues only at SHL 5 (B). Values in parentheses
correspond to ASAN7 (A˚
2). Movement of the 50 G into the minor
groove (A) or major groove (B; green arrows) must accompany MFA
formation, indicating some degree of ﬂexibility at this site.
(C) Oligonucleotide crystal structure of an oxPt-GG cross-link (36)
(base pair displacement into the major/minor grooves via shift, black
arrows). (D) DNA structural parameters for the GG dinucleotide
steps at SHL ±5 in the native NCP146b structure and in the oligo-
nucleotide crystal structures of oxPt-GG (36) and cisPt-GG (26)
cross-links.
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The cross-link formation proﬁles between the naked
and nucleosomal states are overall alike and in fact
more similar to each other than are the footprints between
the different bifunctional agents (Figure 4). This indicates
that cross-linking potential is primarily determined at the
DNA sequence level and moreover implies that there is a
considerable degree of similarity in sequence-dependent
structure and ﬂexibility between the two DNA states.
Nonetheless, as we had observed in our previous study
on NCP147 (16), at certain sites there are signiﬁcant dif-
ferences in the cross-linking proﬁles between the naked
and nucleosomal states for the multiple substrates
studied here. The tight systematic wrapping of the double
helix produces regions where the DNA appears forced to
deviate from its intrinsic preferences—including central
locations, minor groove-inward positions and regions of
stretching (1214,28,34)—and these are the areas where
one sees the greatest distinctions in cross-linking relative
to naked DNA.
DNA conformation modulates Pt adduct formation and
it appears that histone octamer association is capable of
modifying the adduct formation proﬁle by moreover
altering DNA conformation/dynamics. This structure-
based modulation can impact both MFA formation and
chelation and an example of this are the prominent GC
interstrand cross-links over the central nucleosome core
region, for which the alternating shift and high slide
values associated with smooth bending into the minor
groove (34) are likely faciliatory. On the other hand, dif-
ferences between the DNA-cross-link formation proﬁles of
cisPt, carPt and oxPt are well known (3,4,16), and we also
observe pronounced compound-speciﬁc differences in the
footprints (Figure 4). With the substrates utilized in this
study, one sees that the agents differing in only leaving
groups (chloride versus dicarboxylate) give rise to more
similar footprints than those that differ in only the carrier
groups (NH3 versus DACH). Considering that the crys-
tallographic data for tamPt and oxPt show that these two
compounds, which differ markedly in both leaving and
carrier groups, yield highly similar MFA proﬁles
(r=0.73; Supplementary Figure S16) suggests that—in
addition to modulation of MFA formation by Pt
species-speciﬁc steric and electrostatic factors—cross-
linking distinctions also arise from differences in the
kinetics of chelation.
The SHL ±1.5 DNA region is a general hotspot of
adduct formation considering all of the data together,
which is especially notable, since the corresponding
Figure 7. Mechanistic features of Pt drug adduct formation. (A) The relationship between monofunctional association of octahedral transition
metals (left) and MFA formation by square planar Pt compounds (centre and right). The model proposed to illustrate (monoaquated) cisPt reaction
(centre to right) is identical to the structure of Mn2+-pentahydrate bound to an AGG element in NCP147 [left (32); atoms were only removed or
recoloured]. The central guanine base (accessible G) has an elevated ASAN7 as a result of shift at the 5
0 and 30 sides (black arrows), which promotes
metal bond formation. Hydrogen bonds appear as black dashed lines. (B) Model, based on idealized GGG trinucleotides, illustrating general factors
controlling the kinetics of Pt adduct formation. Steric/solvent accessibility of the N7 atom, which is mainly governed by shift (black arrows),
promotes MFA formation (centre). Consequently, a purine base to the 50 side is in a much more favourable conﬁguration, compared to a purine base
to the 30 side, for chelation to occur (right).
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histone binding motif has the greatest DNA distorting and
positioning potential in the nucleosome (14). Conversely,
well positioning DNAs will tend to have ﬂexible sequence
elements over this region, which most likely generally
promotes cross-link formation. The adducts that form
over the SHL ±1.5 AGGCA and AGGGA elements
entail a combination of intrastrand AG and GG and inter-
strand GC cross-links depending on the agent, DNA state
and construct. However, the extent of cross-linking at
SHL ±1.5 in the nucleosomal relative to the naked state
is notably stronger for oxPt/clPt compared to cisPt/carPt
(Figure 4). Considering that we nonetheless observe
pronounced MFA formation by tamPt and cisPt at these
locations in the crystal suggests that the oxPt/clPt carrier
group is more conducive to chelation, at this site, relative
to the carrier groups of cisPt/carPt. In this sense, the re-
duced degree of kink distortion associated with an oxPt
relative to a cisPt intrastrand cross-link, as gleaned from
the oligonucleotide crystal structures (26,36; Figure 6D),
may be more readily accommodated at this location.
Moreover, as a minor groove-inward position, the DNA
at SHL ±1.5 is bent in the opposite direction, making an
oxPt cross-link effectively closer to the native conform-
ation than a cisPt cross-link. Therefore, in a broad sense,
as we have seen with the oxPt crystallographic data in
comparing two other sites of identical sequence, MFA
sites with pre-cross-linking conformations closer to that
of the cross-linked state are likely to undergo chelation
more rapidly (Figure 7B). This is also supported by the
observation that DNA containing a preformed cisPt
cross-link adopts major groove-inward positions on the
histone octamer, which allows the major groove kink dis-
tortion to coincide with the native DNA bending direction
(38). However, we have found no systematic bias towards
cross-link generation at major versus minor groove-
inward positions in the nucleosome across diverse sequence
elements (other prominent cisPt and carPt cross-links can
be seen at minor groove-inward locations; Figure 4), and
this is apparently a consequence of an overall dominance
of intrinsic DNA sequence-dependent behaviour in
dictating cross-linking potential (16).
Understanding the kinetic factors that govern cross-link
formation is important, since the MFAs of current Pt
drugs are apparently therapeutically ineffective (2), and
a key observation is that chelation is generally 10-fold
more rapid in the 50 versus the 30 direction for purine–
purine dinucleotide sites (6,39). This underlies the occur-
rence of long-lived MFAs that are situated 50 to a poten-
tial cross-linking base, which has been suggested to be a
consequence of the Pt center being much closer to an N7
atom at the 50 side (40). In addition, however, the fact that
DNA conformations associated with an accessible
guanine base are the most rapid sites of MFA formation
means that potential cross-linking locations will tend to
have a 50 chelation site in an especially favourable conﬁg-
uration relative to the conversely highly unfavourable one
associated with the 30 direction (Figure 7B). Speciﬁcally,
the pre-cross-linking shift conﬁguration relative to attack
in the 50 direction is much more similar to cross-link struc-
tures (Figure 6D).
Our ﬁndings reveal how Pt drug-speciﬁc and DNA
site-dependent inﬂuences can yield non-uniform adduct
formation proﬁles not predicted from the purine distribu-
tion alone. In addition, the basic principles we have
elucidated can provide a platform for developing more
site selective metalloagents, possibly through exploitation
of DNA structure-based modulation and additional fea-
tures afforded by the proximal histone proteins in the nu-
cleosome (9). For instance, carrier groups imposing
speciﬁc steric challenges towards adduct formation, espe-
cially hindrance above or below the square Pt2+ plane,
could potentially eliminate a host of counterproductive
cellular targets. Finally, we note that the underlying struc-
tural principles governing base reactivity are likely
relevant to many other DNA modifying species.
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